🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, open-label, phase II clinical trial that aims ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06385873
Treatments Being Tested
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
The study is to evaluate the R0 resection rate of patients with unresectabl...
Status
Terminated
Location
Zhejiang procincial people's hospital
Start Date
2017-11-20
Trial ID
NCT03585062
Treatments Being Tested
This is a non-interventional study，aim to observe the safety and efficiency...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03237507
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This is a prospective, multicenter, randomized, phase II clinical trial int...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-03-15
Trial ID
NCT07474324
Treatments Being Tested
Bevacizumab plus capecitabin is a standard maintenance treatment following ...
Status
Withdrawn
Location
Rongbo Lin
Start Date
2018-11
Trial ID
NCT03708536
Treatments Being Tested
The primary objective of this study is to determine the recommended phase I...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00479076
Treatments Being Tested
This multicenter, randomized, double-blind phase III study intends to recru...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-02-10
Trial ID
NCT05180734
Treatments Being Tested
To evaluate the efficacy and safety of Sintilimab in Combination With S-1/o...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-03-01
Trial ID
NCT06046963